REMODEL, sponsored by Entellus, is the first prospective, multi-center, randomized, controlled trial with sufficient statistical power to compare Balloon Sinus Dilation to traditional Functional Endoscopic Sinus Surgery (FESS) for the treatment of chronic or recurrent sinusitis. The results confirm past studies on the safety and effectiveness of Entellus balloon technology, and affirm that office balloon dilation should be an integral part of the continuum of care for patients with uncomplicated sinusitis. The REMODEL study results show: - Balloon dilation and FESS deliver comparable, significant long-term symptom relief and durability - Balloon patients and FESS patients had similar SNOT-20 symptomatic relief - The results for balloon patients were significantly better than FESS in terms of: Fewer post-op debridements Time to return to normal activities Better and quicker short-term symptom relief Click here to request the complete REMODEL study publication.
Posted on: Thu, 05 Sep 2013 02:15:49 +0000
Trending Topics
Recently Viewed Topics
© 2015